Takeda's Massive Layoffs: Cambridge's Biotech Blow
Boston News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Takedas Massive Layoffs: A Strategic Restructuring for Long-Term Growth
Takeda, a biopharma giant based in Massachusetts, is set to lay off nearly 250 employees at its Kendall Street location, starting in July and extending into 2026 and 2027. This move is part of a major company restructure aimed at sharpening focus and accelerating the rollout of new medicines. Incoming CEO Julie Kim frames the cuts as necessary steps to speed up breakthroughs from their pipeline. This is not the first time Takeda has made significant job cuts, having previously slashed hundreds of local jobs and ditched more in Cambridge. Additionally, Takeda is reshaping its Cambridge presence by subletting over 630,000 square feet and moving to a new research hub at 585 Kendall Street. The biotech scene in Massachusetts is feeling the heat, with Moderna and Thermo Fisher Scientific also announcing recent layoffs.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/309a59ac0b342a31